ID   SC4 [Mouse schwannoma]
AC   CVCL_JK03
DR   Wikidata; Q54952286
RX   PubMed=17234759;
RX   PubMed=28469964;
CC   Knockout cell: Method=KO mouse; MGI; MGI:97307; Nf2 (Note=Conditional KO).
CC   Derived from site: In situ; Peripheral nervous system, nerve; UBERON=UBERON_0001021.
CC   Cell type: Schwann cell; CL=CL_0002573.
DI   NCIt; C21997; Mouse schwannoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
CA   Cancer cell line
DT   Created: 15-05-17; Last updated: 30-01-24; Version: 6
//
RX   PubMed=17234759; DOI=10.1158/0008-5472.CAN-06-1608;
RA   Morrison, Helen
RA   Sperka, Tobias
RA   Manent, Jan
RA   Giovannini, Marco
RA   Ponta, Helmut
RA   Herrlich, Peter
RT   "Merlin/neurofibromatosis type 2 suppresses growth by inhibiting the
RT   activation of Ras and Rac.";
RL   Cancer Res. 67:520-527(2007).
//
RX   PubMed=28469964; PMCID=PMC5411799;
RA   Guo, Jian-Man
RA   Grovola, Michael R.
RA   Xie, Hong
RA   Coggins, Grace E.
RA   Duggan, Patrick
RA   Hasan, Rukhsana
RA   Huang, Jia-Le
RA   Lin, Danny W.
RA   Song, Claire
RA   Witek, Gabriela M.
RA   Berritt, Simon
RA   Schultz, David C.
RA   Field, Jeffrey
RT   "Comprehensive pharmacological profiling of neurofibromatosis cell
RT   lines.";
RL   Am. J. Cancer Res. 7:923-934(2017).
//